CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro
Authors
Keywords
-
Journal
Cells
Volume 11, Issue 22, Pages 3692
Publisher
MDPI AG
Online
2022-11-21
DOI
10.3390/cells11223692
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ex Vivo Generation of CAR Macrophages from Hematopoietic Stem and Progenitor Cells for Use in Cancer Therapy
- (2022) Daniela Paasch et al. Cells
- Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies
- (2022) Siyu Su et al. Cells
- Intracavity generation of glioma stem cell–specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy
- (2022) Chen Chen et al. Science Translational Medicine
- Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
- (2022) Chenyi Luo et al. Frontiers in Oncology
- Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat Cancer
- (2022) Carlos Moreno et al. Biomedicines
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer Therapy
- (2021) Mikyung Kang et al. ADVANCED MATERIALS
- CAR-macrophage: A new immunotherapy candidate against solid tumors
- (2021) Yizhao Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
- (2021) Kathryn M. Cappell et al. Nature Reviews Clinical Oncology
- CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies
- (2021) Shifaa M. Abdin et al. Journal for ImmunoTherapy of Cancer
- Inflammatory macrophages exploit unconventional pro-phagocytic integrins for phagocytosis and anti-tumor immunity
- (2021) Zhenghai Tang et al. Cell Reports
- Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
- (2021) Christopher Sloas et al. Frontiers in Immunology
- Interleukin-23 engineering improves CAR T cell function in solid tumors
- (2020) Xingcong Ma et al. NATURE BIOTECHNOLOGY
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- Rational Cancer Treatment Combinations: An Urgent Clinical Need
- (2020) Julia Boshuizen et al. MOLECULAR CELL
- CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
- (2019) Mohamad Hamieh et al. NATURE
- CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
- (2018) Theodoros Giavridis et al. NATURE MEDICINE
- Chimeric antigen receptors that trigger phagocytosis
- (2018) Meghan A Morrissey et al. eLife
- SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin
- (2017) Jun Chen et al. NATURE
- The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity
- (2016) Rune Busk Damgaard et al. CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More